Latest news with #KindlyMD
Yahoo
4 days ago
- Business
- Yahoo
KindlyMD Acquires 21 Bitcoin Ahead of Merger with Nakamoto
KindlyMD (NAKA), an integrated healthcare services provider, has pulled the trigger on its bitcoin BTC treasury strategy. The acquired 21 bitcoin for roughly $2.3 million at an average cost of $109,027, according to a Tuesday press release. The purchase was funded by exercising some of the company's outstanding warrants. 'Our first 1/millionth of all bitcoin, on our way to owning 1,000,000 bitcoin,' David Bailey, founder and CEO of Nakamoto Holdings, posted on X. '1 Nakamoto = 1m Bitcoin,' he added. NAKA is higher by 3.9% on Tuesday. KindlyMD announced on May 12 that it had agreed to merge with Nakamoto Holdings in order to pursue a bitcoin accumulation strategy mirrored after Strategy's (MSTR) playbook. The combined entity secured $710 million in financing. KindlyMD and Nakamoto will also partner up with custody firm Anchorage Digital to provide exclusive custody and trading services to the company post-merger, KindlyMD announced on May 21. The merger is expected to close in the third quarter of 2025. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
4 days ago
- Business
- Business Wire
KindlyMD Makes Initial Purchase of 21 Bitcoin as Part of its Treasury Strategy
SALT LAKE CITY--(BUSINESS WIRE)--Kindly MD, Inc. (NASDAQ: NAKA) ('KindlyMD' or the 'Company'), a leading provider of integrated healthcare services, today announced that it has purchased 21 Bitcoin at a weighted average price of $109,027 per Bitcoin for approximately $2.3 million. The Company made this initial purchase of Bitcoin using a portion of the $8,748,370 gross proceeds received from the exercise of some of the Company's outstanding warrants, resulting in the issuance of 1,437,362 shares of common stock of the Company. The purchase aligns with the Company's vision to adopt a Bitcoin treasury strategy through its proposed merger with Nakamoto Holdings Inc. ('Nakamoto'), a Bitcoin-native holding company. 'KindlyMD chose 21 BTC, which is one millionth of the total supply of bitcoin, as a symbolic first step on our journey to be the leading Bitcoin treasury strategy,' said David Bailey, Founder and CEO of Nakamoto. 'There are many more milestones ahead and we can't wait to continue to execute our roadmap with KindlyMD.' 'There is excitement among our investors going into the 2025 Bitcoin Conference in Las Vegas and today's announcement reinforces our commitment to accumulate Bitcoin and drive long-term value for our shareholders,' said Tim Pickett, CEO of KindlyMD. 'This strategic purchase was possible after significant warrant redemption, which we believe reflects our investor's support of the merger and in our confidence of Bitcoin as a store of value. We look forward to working diligently towards the closing of our merger with Nakamoto to further accelerate our Bitcoin treasury strategy.' About Nakamoto Nakamoto is a Bitcoin treasury company building a global portfolio of Bitcoin-native companies. Nakamoto plans to establish the first publicly traded conglomerate of Bitcoin companies by accumulating Bitcoin in its treasury and by leveraging its treasury to acquire and develop an ecosystem of Bitcoin companies across finance, media, advisory and more. The company aims to provide commercial and financial infrastructure for the next generation of capital markets. For more information, please visit About KindlyMD KindlyMD is a patient-first healthcare and healthcare data company redefining value-based care and patient-centered medical services. KindlyMD leverages data analysis to deliver evidence-based, personalized solutions in order to reduce opioid use, improve health outcomes faster, and provide algorithmic guidance on the use of alternative medicine in healthcare. KindlyMD provides a patient-focused healthcare experience that integrates traditional medical evaluation and management with mental health integration and compliant alternative medicine education and inclusion. It focuses on creating personalized care plans for each individual that get people back to work and life faster, reduce opioid use, and yield high patient satisfaction. Its specialty outpatient clinical services are reimbursed by Medicare, Medicaid, and commercial insurance contracts as well as offered on a fee-for-service basis. For more information, please visit Forward-Looking Statements All statements, other than statements of historical fact, included in this release that address activities, events or developments that KindlyMD or Nakamoto expects, believes or anticipates will or may occur in the future are forward-looking statements. Words such as 'estimate,' 'project,' 'predict,' 'believe,' 'expect,' 'anticipate,' 'potential,' 'create,' 'intend,' 'could,' 'would,' 'may,' 'plan,' 'will,' 'guidance,' 'look,' 'goal,' 'future,' 'build,' 'focus,' 'continue,' 'strive,' 'allow' or the negative of such terms or other variations thereof and words and terms of similar substance used in connection with any discussion of future plans, actions, or events identify forward-looking statements. However, the absence of these words does not mean that the statements are not forward-looking. These forward-looking statements include, but are not limited to, statements regarding the proposed merger and related transactions, (collectively, the 'Transactions') the expected closing of the proposed Transactions and the timing thereof and as adjusted descriptions of the post-transaction company and its operations, strategies and plans, integration, debt levels and leverage ratio, capital expenditures, cash flows and anticipated uses thereof, synergies, opportunities and anticipated future performance, including the management team and board of directors of the combined company and expected use of proceeds from the Transactions, and any post-closing transactions contemplated between the combined company and BTC Inc (and/or UTXO, LLC through BTC Inc). Information adjusted for the proposed Transactions should not be considered a forecast of future results. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements included in this release. These include the risk that KindlyMD and Nakamoto businesses (which may include the businesses of BTC Inc and/or UTXO in the future, as applicable) will not be integrated successfully and the risk that KindlyMD or the applicable governing bodies of BTC Inc and/or UTXO may not pursue or approve the terms of an acquisition of BTC Inc and/or UTXO; the risk that cost savings, synergies and growth from the proposed transaction may not be fully realized or may take longer to realize than expected; the possibility that shareholders of KindlyMD may not approve the issuance of new shares of KindlyMD common stock in the Transactions or that shareholders of KindlyMD may not approve the Transactions; the risk that a condition to closing of the Transactions may not be satisfied, that either party may terminate the merger agreement, the subscription agreements of the convertible debt purchase agreement or that the closing of the Transactions might be delayed or not occur at all; potential adverse reactions or changes to business or employee relationships, including those resulting from the announcement or completion of the Transactions; the parties do not receive regulatory approval of the Transactions; the occurrence of any other event, change, or other circumstances that could give rise to the termination of the merger agreement relating to the Transactions; the risk that changes in KindlyMD's capital structure and governance could have adverse effects on the market value of its securities; the ability of KindlyMD and Nakamoto to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers and on KindlyMD and Nakamoto's operating results and business generally; the risk the Transactions could distract management from ongoing business operations or cause KindlyMD and/or Nakamoto to incur substantial costs; the risk that KindlyMD may be unable to reduce expenses or access financing or liquidity; the impact of any related economic downturn; the risk of changes in governmental regulations or enforcement practices; and other important factors that could cause actual results to differ materially from those projected. All such factors are difficult to predict and are beyond KindlyMD's and Nakamoto's control, including those detailed in KindlyMD's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and such other documents of KindlyMD filed, or to be filed, with the SEC that are or will be available on KindlyMD's website at and on the website of the SEC at . All forward-looking statements are based on assumptions that KindlyMD and Nakamoto believe to be reasonable but that may not prove to be accurate. Any forward-looking statement speaks only as of the date on which such statement is made, and neither KindlyMD or Nakamoto undertakes any obligation to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.
Business Wire
23-05-2025
- Business
- Business Wire
KindlyMD ® Announces NASDAQ Ticker Symbol Change to ‘NAKA' Effective May 23, 2025
SALT LAKE CITY--(BUSINESS WIRE)--KindlyMD, Inc. (NASDAQ: NAKA) (NASDAQ: KDLY) ('KindlyMD' or the 'Company'), a leading provider of integrated healthcare services, today announced it has changed its ticker from 'KDLY' to 'NAKA' on the Nasdaq Stock Exchange. The ticker for the Company's tradable warrants has also been changed from 'KDLYW' to 'NAKAW'. The Company's common stock and warrants will begin trading under the new tickers beginning today, Friday, May 23, 2025. The change reflects the Company's new vision to adopt a Bitcoin treasury strategy through its proposed merger with Nakamoto Holdings Inc. ('Nakamoto'), a Bitcoin-native holding company. The ticker change also follows the recent approval of the merger agreement and related transactions by the Company's majority shareholders and the approval by the Utah Department of Commerce for the Company to do business under the name 'Nakamoto'. 'KindlyMD's new ticker symbol pays homage to Satoshi Nakamoto, the father of Bitcoin. Like prominent financial institutions of the past, we believe that the name 'Nakamoto' and its legacy will become renowned,' said David Bailey, Founder and CEO of Nakamoto. 'We are grateful that KindlyMD shares this vision and is excited to forge this next chapter with us.' Tim Pickett, CEO of KindlyMD, added, 'We are excited to unveil the ticker that will define our partnership with Nakamoto. This ticker change allows us to unite our patient-first healthcare mission with Nakamoto's deep expertise in Bitcoin, creating new opportunities for innovation, growth, and long-term value for our shareholders.' As of May 23, 2025, KindlyMD's securities trading, regulatory filings, and market-related information will be reported under the new symbols 'NAKA' and 'NAKAW'. No action is required by existing shareholders with respect to the ticker symbol change. About Nakamoto Nakamoto is a Bitcoin treasury company building a global portfolio of Bitcoin-native companies. Nakamoto plans to establish the first publicly traded conglomerate of Bitcoin companies by accumulating Bitcoin in its treasury and by leveraging its treasury to acquire and develop an ecosystem of Bitcoin companies across finance, media, advisory and more. The company aims to provide commercial and financial infrastructure for the next generation of capital markets. For more information, please visit About KindlyMD KindlyMD is a patient-first healthcare and healthcare data company redefining value-based care and patient-centered medical services. KindlyMD leverages data analysis to deliver evidence-based, personalized solutions in order to reduce opioid use, improve health outcomes faster, and provide algorithmic guidance on the use of alternative medicine in healthcare. KindlyMD provides a patient-focused healthcare experience that integrates traditional medical evaluation and management with mental health integration and compliant alternative medicine education and inclusion. It focuses on creating personalized care plans for each individual that get people back to work and life faster, reduce opioid use, and yield high patient satisfaction. Its specialty outpatient clinical services are reimbursed by Medicare, Medicaid, and commercial insurance contracts as well as offered on a fee-for-service basis. For more information, please visit Forward-Looking Statements All statements, other than statements of historical fact, included in this release that address activities, events or developments that KindlyMD or Nakamoto expects, believes or anticipates will or may occur in the future are forward-looking statements. Words such as 'estimate,' 'project,' 'predict,' 'believe,' 'expect,' 'anticipate,' 'potential,' 'create,' 'intend,' 'could,' 'would,' 'may,' 'plan,' 'will,' 'guidance,' 'look,' 'goal,' 'future,' 'build,' 'focus,' 'continue,' 'strive,' 'allow' or the negative of such terms or other variations thereof and words and terms of similar substance used in connection with any discussion of future plans, actions, or events identify forward-looking statements. However, the absence of these words does not mean that the statements are not forward-looking. These forward-looking statements include, but are not limited to, statements regarding the proposed merger and related transactions, (collectively, the 'Transactions') the expected closing of the proposed Transactions and the timing thereof and as adjusted descriptions of the post-transaction company and its operations, strategies and plans, integration, debt levels and leverage ratio, capital expenditures, cash flows and anticipated uses thereof, synergies, opportunities and anticipated future performance, including the management team and board of directors of the combined company and expected use of proceeds from the Transactions, and any post-closing transactions contemplated between the combined company and BTC Inc (and/or UTXO, LLC through BTC Inc). Information adjusted for the proposed Transactions should not be considered a forecast of future results. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements included in this release. These include the risk that KindlyMD and Nakamoto businesses (which may include the businesses of BTC Inc and/or UTXO in the future, as applicable) will not be integrated successfully and the risk that KindlyMD or the applicable governing bodies of BTC Inc and/or UTXO may not pursue or approve the terms of an acquisition of BTC Inc and/or UTXO; the risk that cost savings, synergies and growth from the proposed transaction may not be fully realized or may take longer to realize than expected; the possibility that shareholders of KindlyMD may not approve the issuance of new shares of KindlyMD common stock in the Transactions or that shareholders of KindlyMD may not approve the Transactions; the risk that a condition to closing of the Transactions may not be satisfied, that either party may terminate the merger agreement, the subscription agreements of the convertible debt purchase agreement or that the closing of the Transactions might be delayed or not occur at all; potential adverse reactions or changes to business or employee relationships, including those resulting from the announcement or completion of the Transactions; the parties do not receive regulatory approval of the Transactions; the occurrence of any other event, change, or other circumstances that could give rise to the termination of the merger agreement relating to the Transactions; the risk that changes in KindlyMD's capital structure and governance could have adverse effects on the market value of its securities; the ability of KindlyMD and Nakamoto to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers and on KindlyMD and Nakamoto's operating results and business generally; the risk the Transactions could distract management from ongoing business operations or cause KindlyMD and/or Nakamoto to incur substantial costs; the risk that KindlyMD may be unable to reduce expenses or access financing or liquidity; the impact of any related economic downturn; the risk of changes in governmental regulations or enforcement practices; and other important factors that could cause actual results to differ materially from those projected. All such factors are difficult to predict and are beyond KindlyMD's and Nakamoto's control, including those detailed in KindlyMD's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and such other documents of KindlyMD filed, or to be filed, with the SEC that are or will be available on KindlyMD's website at and on the website of the SEC at All forward-looking statements are based on assumptions that KindlyMD and Nakamoto believe to be reasonable but that may not prove to be accurate. Any forward-looking statement speaks only as of the date on which such statement is made, and neither KindlyMD or Nakamoto undertakes any obligation to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.
Business Mayor
22-05-2025
- Business
- Business Mayor
KindlyMD, Nakamoto, and Anchorage Digital Form Strategic Bitcoin Treasury Alliance
Nakamoto Holdings Inc., KindlyMD, Inc., and Anchorage Digital today announced a strategic partnership that will see Anchorage become a trading partner for KindlyMD's Bitcoin treasury. The partnership will officially take effect upon the close of KindlyMD's merger with Nakamoto, expected in Q3 2025. Anchorage Digital, a U.S. federally chartered digital asset bank, will provide institutional-grade custody, 24/7 trading, and deep liquidity to support the Bitcoin strategy of the combined entity. 'In the not-so-distant-future, the omission of Bitcoin on a balance sheet will be more glaring than its inclusion,' said Nathan McCauley, CEO and Co-Founder of Anchorage Digital. 'Until then, companies like Nakamoto-KindlyMD are pioneering a new path forward—one in which Bitcoin is at the heart of corporate strategy.' The merger between KindlyMD and Nakamoto is backed by approximately $710 million in financing, including $510 million in PIPE funding—the largest ever PIPE for a public crypto-related deal. The goal is to establish a Bitcoin-native corporate treasury strategy that redefines how capital markets engage with digital assets. 'Our goal is to bring Bitcoin to the center of global capital markets within a compliant, transparent structure,' said David Bailey, Founder and CEO of Nakamoto Holdings Inc. 'We are excited to partner with Anchorage Digital to implement our vision with the highest levels of security and battle-tested infrastructure and enable us to deliver sustained value to shareholders.' This announcement follows a key milestone on May 18, when KindlyMD shareholders approved the proposed merger with Nakamoto. The transaction is now expected to close in Q3 2025, pending SEC review and information statement distribution. 'This milestone brings us one step closer to unlocking Bitcoin's potential for KindlyMD shareholders,' Bailey said yesterday. 'We are grateful that KindlyMD shares our vision for a future in which Bitcoin is a core part of the corporate balance sheet.' With its Bitcoin-first strategy and strategic alliances, the Nakamoto-KindlyMD partnership is set to accelerate institutional Bitcoin adoption—and with Anchorage Digital's infrastructure behind it, the foundation is now firmly in place. 'By collaborating with Anchorage Digital, we are implementing our Bitcoin treasury strategy with the utmost standards in safety and security for our shareholders,' stated Tim Pickett, CEO of KindlyMD. 'Their institutional-grade platform allows us to confidently hold Bitcoin as a treasury asset as we look to unlock access to Bitcoin and drive value for the long term.' Disclosure: Nakamoto is in partnership with Bitcoin Magazine's parent company BTC Inc to build the first global network of Bitcoin treasury companies, where BTC Inc provides certain marketing services to Nakamoto. More information on this can be found here . READ SOURCE
Yahoo
21-05-2025
- Business
- Yahoo
Surprising stock jumps over 30% after SEC confirms merger
Shares of KindlyMD, Inc. (Nasdaq: KDLY) soared over 30% on May 21 after the healthcare firm confirmed via an SEC filing that its shareholders have approved a high-profile merger with Bitcoin company Nakamoto Holdings. The post-market filing sent KDLY from $15.22 to $19.83 in a day, continuing an astonishing rally with shares up over 1,127% year-to-date. Bitcoin-native businesses hold Bitcoin as part of their treasury strategy. The parties disclosed the deal on May 12. They anticipated closing within the third quarter of 2025 after a 20-day notice period when both companies file their informational statement with the SEC. This merger represents a sea change for Kindly MD, which is historically a healthcare provider and is now a Bitcoin investment vehicle. Nakamoto Holdings was founded by Bitcoin Magazine CEO David Bailey, who advised Donald Trump on crypto policy during the 2024 presidential campaign. Per the statement, the combined company will use equity, debt, and other instruments to finance its Bitcoin-related growth. This deal underscores how traditional companies are pursuing crypto-like exposure, particularly in Bitcoin, which many believe is a long-term store of value. KDLY's explosive rise has also motivated other healthcare companies to integrate Bitcoin as part of their treasury strategy. On May 16, Basel Medical, a Singapore-based healthcare organization, announced plans for a $1 billion Bitcoin deal to provide liquidity to its balance sheet. As per Kraken, Bitcoin was trading at $107,215 at press time, only 2% short of its record high.
